Insmed (INSM.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec11

Nebula Research Increased Stake in Insmed Inc.

12:44

Dec10

Insmed Director Sells $4.1M in Shares, Rothschild Upgrades to Buy

03:12

Dec9

Insmed to Present Data on Treprostinil and Brensocatib at European Respiratory Society Congress

15:36

Dec5

Insmed Inc Director Plans to Sell 20,000 Restricted Shares

22:46

William Lewis, CEO of Insmed Inc., Disposed of Company Common Stock

21:12

Dec3

Insmed Inc. CMO Reports Disposition of Common Stock

21:02

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 142.34 M, Net Income -370.02 M, EPS -1.75

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 107.42 M, Net Income -321.69 M, EPS -1.7

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 92.82 M, Net Income -256.58 M, EPS -1.42

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More